NCI National Clinical Trials Network (NCTN) Program Guidelines

NCI National Clinical Trials Network (NCTN) Program Guidelines NCI National Clinical Trials Network (NCTN) Program Guidelines

ctep.cancer.gov
from ctep.cancer.gov More from this publisher
12.01.2013 Views

PART 1: Overview of NCTN Program Section III – General Management & Network Operating/Funding Principles 2.4 Adult Network Group Member Institutions/Sites Funding NCI/DCTD funding given to an adult Network Group Operations Center for its member institutions/sites which are not Lead Academic Participating Sites, CCOPs, or MB-CCOPs is provided to these sites through purchase service agreements or subcontracts using an algorithm for “Basic Intervention Per Case Management” funding as well as other funding “Per Case” categories as specified in Part 4: Appendices – Section IV for patient enrollment to the entire portfolio of NCTN trials that these member institutions/sites credit to the adult Network Group Operations Center. These members will also be eligible for special program/initiative for “High-Performance” sites administrated via the CTSU as described below. 2.5 Categories of “Per Case Management” Funding The various categories of NCI/DCTD supported “per case management” funding are described below. � Screening Per Case Management Funding: Funding to cover data management costs for patients enrolled on a trial that require specific screening with informed consent as part of the trial (e.g., investigational molecular test of their tumor) and who do not subsequently undergo the study treatment/intervention and/or randomization because of the screening results. � Basic Intervention Per Case Management Funding: Funding to cover data management costs for enrolled patients who undergo the study treatment/intervention and/or randomization. Basic intervention funding is divided into therapeutic (treatment intervention or pilot studies) or advanced imaging interventions. This base amount is set at the same level for all treatment trials; however, the base amount for advanced imaging trials may be different. This funding category also includes funding for average follow-up per case data management for an NCTN trial (i.e., separate payments for follow-up are not provided). Please note that the basic intervention per case cost includes any screening performed on study (i.e., per case funding is provided for an enrolled patient for either screening or intervention but not both). Likewise, intervention per case management funding is provided at either the basic level or the high-performance level, but not both – see the information on high-performance intervention per case management funding below. � Advanced Imaging Trial Per Case Management Funding: Funding to cover data management and imaging costs for complex imaging used in advanced imaging trials (above the base intervention per case amount described above) would be provided to all NCTN participating sites by the Network Group Operations Center with a specialty focus in this area that leads these trials (including providing the funding to other Network Group Operations Centers for their members which participate in the trials) as these studies are expected to be limited in number relative to the number of treatment trials. � Biospecimen Collection Per Case Management Funding: Funding to cover biospecimen collection and any associated management costs for patients enrolled on study who undergo the study treatment/intervention and/or randomization for trials with required or optional biospecimen collections – this category of funding would not be expected to be given in association with screening per case funding except in unusual circumstances. � Special Per Case Management Funding: Funding to cover additional data collection/management costs for patients enrolled on study who undergo the study treatment/intervention and/or randomization, usually for very complex trials and/or trials in rare disease areas or rare disease subsets as well as any special ancillary study funding. This category of funding is approved by NCI/DCTD on a trial by trial basis only. � High-Performance Intervention Per Case Management Funding for Lead Academic Participating Sites, CCOPs/MB-CCOPs and Member Institutions/Sites of the Pediatric Network Group: Funding Page 28 of 241

PART 1: Overview of NCTN Program Section III – General Management & Network Operating/Funding Principles to cover additional data management costs/workload and follow-up at institutions (with acceptable audit standings) that enroll a large number of patients (based on specific threshold levels set by NCI/DCTD for pediatric patient enrollment and for adult patient enrollment on NCTN trials (with adult thresholds designated by NCI/DCTD for CCOP and MB-CCOP vs. Lead Academic Participating Sites vs. other Network Group member institutions/sites separately). It is anticipated that this funding will be provided to Lead Academic Participating Sites for accrual at the main academic center if the threshold accrual level for Lead Academic Participating Site awardees is sustained, and it covers all follow-up data management costs for these patients. “High- Performance” per case funding for affiliates that are included in a Lead Academic Participating Site grant award (i.e., if complete management services for the affiliates is provided by the Lead Academic Participating Sites) may be possible, pending funds availability based on whether the affiliates meet special threshold accrual levels for this category of sites set by NCI/DCTD each year as described below. Different accrual targets will be applied to different categories of sites funded via separate grant programs as follows: (1) Lead Academic Participating Sites (excluding affiliates); and (2) CCOPs and MB-CCOPs; and (3) pediatric sites that are institutional members of the pediatric Network Group Operations Center. The priority for funding of high-performance sites is to cover these 3 categories of sites first providing they meet their threshold levels for accrual. These sites are a priority because they undergo peer-review as high-performing institutional sites from academic and community sites based on accrual potential and scientific leadership. � High-Performance Intervention Per Case Management Funding for Other Member Institutions/Sites for the Adult Network Groups: A special Network initiative will be available on an annual basis to select other categories of “high-performance” sites participating in the NCTN Program, provided funding is available. Selection of these sites is based on a specific accrual threshold level to all trials across the Network set by NCI/DCTD each year. If funding constraints exist at the particular threshold selected in any year, the priority order for funding will be: (1) other U.S. sites not covered by the 3 categories described above (including affiliates of Lead Academic Participating Sites); (2) Canadian sites; and (3) other international sites. Based on their selection as “high-performance” sites, these sites will receive additional infrastructure support during the subsequent year (e.g., support for time and effort for Clinical Research Associates and other health care professions involved in the conduct of NCTN trials, as well as training for support personnel, and travel and equipment needs related to clinical trial conduct) in order to leverage their support for the entire NCTN Program to help ensure the trials are completed more quickly. “Eligibility” for this program will be based on threshold accrual rates for single institutions (not networks of institutions/sites). If an affiliate that is part of a Lead Academic Participating Sites award is eligible for this funding, the funding will be provided via the Lead Academic Participating Site award. Funding for other eligible sites, which do not have NCI grant funding for infrastructure support for activities across the Network, will be made via contract using the NCI Cancer Trials Support Unit (CTSU) under NCI/DCTD’s direction. � Quality of Life Per Case Management Funding: Funding to develop and to cover data collection/management costs associated with patient enrollment in quality of life sub-studies incorporated into NCTN treatment or advanced imaging clinical trials is not provided by NCI/DCTD except in special circumstances as described below. “Quality of Life Per Case Management” funding is provided by the NCI Division of Cancer Prevention (DCP) through its CCOP/MB-CCOP grants and to other member institutions/sites of the Network Groups (including the Network Lead Academic Participating Sites) through DCP grants to the Network Groups as CCOP Research Bases. DCP also provides funding to develop these types of studies through CCOP Research Bases grants to Network Groups. Page 29 of 241

PART 1: Overview of <strong>NCTN</strong> <strong>Program</strong> Section III – General Management & <strong>Network</strong> Operating/Funding Principles<br />

2.4 Adult <strong>Network</strong> Group Member Institutions/Sites Funding<br />

<strong>NCI</strong>/DCTD funding given to an adult <strong>Network</strong> Group Operations Center for its member<br />

institutions/sites which are not Lead Academic Participating Sites, CCOPs, or MB-CCOPs is provided to<br />

these sites through purchase service agreements or subcontracts using an algorithm for “Basic<br />

Intervention Per Case Management” funding as well as other funding “Per Case” categories as<br />

specified in Part 4: Appendices – Section IV for patient enrollment to the entire portfolio of <strong>NCTN</strong><br />

trials that these member institutions/sites credit to the adult <strong>Network</strong> Group Operations Center.<br />

These members will also be eligible for special program/initiative for “High-Performance” sites<br />

administrated via the CTSU as described below.<br />

2.5 Categories of “Per Case Management” Funding<br />

The various categories of <strong>NCI</strong>/DCTD supported “per case management” funding are described below.<br />

� Screening Per Case Management Funding: Funding to cover data management costs for patients<br />

enrolled on a trial that require specific screening with informed consent as part of the trial (e.g.,<br />

investigational molecular test of their tumor) and who do not subsequently undergo the study<br />

treatment/intervention and/or randomization because of the screening results.<br />

� Basic Intervention Per Case Management Funding: Funding to cover data management costs for<br />

enrolled patients who undergo the study treatment/intervention and/or randomization. Basic<br />

intervention funding is divided into therapeutic (treatment intervention or pilot studies) or<br />

advanced imaging interventions. This base amount is set at the same level for all treatment trials;<br />

however, the base amount for advanced imaging trials may be different. This funding category<br />

also includes funding for average follow-up per case data management for an <strong>NCTN</strong> trial (i.e.,<br />

separate payments for follow-up are not provided). Please note that the basic intervention per<br />

case cost includes any screening performed on study (i.e., per case funding is provided for an<br />

enrolled patient for either screening or intervention but not both). Likewise, intervention per case<br />

management funding is provided at either the basic level or the high-performance level, but not<br />

both – see the information on high-performance intervention per case management funding<br />

below.<br />

� Advanced Imaging Trial Per Case Management Funding: Funding to cover data management and<br />

imaging costs for complex imaging used in advanced imaging trials (above the base intervention<br />

per case amount described above) would be provided to all <strong>NCTN</strong> participating sites by the<br />

<strong>Network</strong> Group Operations Center with a specialty focus in this area that leads these trials<br />

(including providing the funding to other <strong>Network</strong> Group Operations Centers for their members<br />

which participate in the trials) as these studies are expected to be limited in number relative to the<br />

number of treatment trials.<br />

� Biospecimen Collection Per Case Management Funding: Funding to cover biospecimen collection<br />

and any associated management costs for patients enrolled on study who undergo the study<br />

treatment/intervention and/or randomization for trials with required or optional biospecimen<br />

collections – this category of funding would not be expected to be given in association with<br />

screening per case funding except in unusual circumstances.<br />

� Special Per Case Management Funding: Funding to cover additional data collection/management<br />

costs for patients enrolled on study who undergo the study treatment/intervention and/or<br />

randomization, usually for very complex trials and/or trials in rare disease areas or rare disease<br />

subsets as well as any special ancillary study funding. This category of funding is approved by<br />

<strong>NCI</strong>/DCTD on a trial by trial basis only.<br />

� High-Performance Intervention Per Case Management Funding for Lead Academic Participating<br />

Sites, CCOPs/MB-CCOPs and Member Institutions/Sites of the Pediatric <strong>Network</strong> Group: Funding<br />

Page 28 of 241

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!